European equities traded in the US as American depositary receipts were trending lower late Wednesday morning, declining 0.51% to 1,719.51 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and biopharmaceutical company DBV Technologies (DBVT), which rose 5.8% and 5.5% respectively. They were followed by telecommunications companies Nokia (NOK) and Ericsson (ERIC), which were up 4.7% and 4% respectively.

The decliners from continental Europe were led by consumer goods company Unilever (UL) and oil and gas company Eni (E), which fell 3.1% and 2.7% respectively. They were followed by lender ING (ING) and semiconductor company Sequans Communications (SQNS), which were down 1.7% and 0.2% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Bicycle Therapeutics (BCYC) and telecommunications company Vodafone Group (VOD), which advanced 4% and 2.3% respectively. They were followed by biopharmaceutical companies Amarin (AMRN) and Mereo BioPharma Group (MREO), which increased 2% and 1.6% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and alcoholic beverage company Diageo (DEO), which lost 5.8% and 4% respectively. They were followed by hospitality company InterContinental Hotels Group (IHG) and biotech firm Trinity Biotech (TRIB), which dropped 2.6% and 2.1% respectively.